Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- And Active Comparator–Controlled, Adaptive Proof-Of-Concept Phase 2 Study
Diabetes Care - United States
doi 10.2337/dc14-1044
Full Text
Open PDFAbstract
Available in full text
Date
September 17, 2014
Authors
Publisher
American Diabetes Association